• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素激动剂与拮抗剂在体外受精-胚胎移植(IVF/ET)中的应用。

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).

机构信息

Unit of Physiopathology of Human Reproduction and Gametes Cryopreservation, Department of Gynecology, Obstetric and Neonatolgy, University of Bari "Aldo Moro", Bari, Italy.

出版信息

Reprod Biol Endocrinol. 2012 Apr 13;10:26. doi: 10.1186/1477-7827-10-26.

DOI:10.1186/1477-7827-10-26
PMID:22500852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3442989/
Abstract

Several protocols are actually available for in Vitro Fertilization and Embryo Transfer. The review summarizes the main differences and the clinic characteristics of the protocols in use with GnRH agonists and GnRH antagonists by emphasizing the major outcomes and hormonal changes associated with each protocol. The majority of randomized clinical trials clearly shows that in "in Vitro" Fertilization and Embryo Transfer, the combination of exogenous Gonadotropin plus a Gonadotropin Releasing Hormone (GnRH) agonist, which is able to suppress pituitary FSH and LH secretion, is associated with increased pregnancy rate as compared with the use of gonadotropins without a GnRH agonist. Protocols with GnRH antagonists are effective in preventing a premature rise of LH and induce a shorter and more cost-effective ovarian stimulation compared to the long agonist protocol. However, a different synchronization of follicular recruitment and growth occurs with GnRH agonists than with GnRH antagonists. Future developments have to be focused on timing of the administration of GnRH antagonists, by giving a great attention to new strategies of stimulation in patients in which radio-chemotherapy cycles are needed.

摘要

有几种方案实际上可用于体外受精和胚胎移植。本综述通过强调与每种方案相关的主要结果和激素变化,总结了使用 GnRH 激动剂和 GnRH 拮抗剂的方案的主要差异和临床特点。大多数随机临床试验清楚地表明,在“体外”受精和胚胎移植中,外源性促性腺激素加促性腺激素释放激素 (GnRH) 激动剂的组合能够抑制垂体 FSH 和 LH 的分泌,与不使用 GnRH 激动剂的促性腺激素相比,妊娠率增加。与长激动剂方案相比,使用 GnRH 拮抗剂的方案可有效防止 LH 过早升高,并诱导更短且更具成本效益的卵巢刺激。然而,与 GnRH 拮抗剂相比, GnRH 激动剂会导致卵泡募集和生长的不同同步。未来的发展必须集中在 GnRH 拮抗剂的给药时间上,同时要特别关注需要进行放化疗周期的患者的新刺激策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b8/3442989/b38667027d6e/1477-7827-10-26-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b8/3442989/9eba3519f396/1477-7827-10-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b8/3442989/ae020fd91624/1477-7827-10-26-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b8/3442989/b38667027d6e/1477-7827-10-26-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b8/3442989/9eba3519f396/1477-7827-10-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b8/3442989/ae020fd91624/1477-7827-10-26-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b8/3442989/b38667027d6e/1477-7827-10-26-3.jpg

相似文献

1
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).促性腺激素释放激素激动剂与拮抗剂在体外受精-胚胎移植(IVF/ET)中的应用。
Reprod Biol Endocrinol. 2012 Apr 13;10:26. doi: 10.1186/1477-7827-10-26.
2
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
3
[Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].[GnRH拮抗剂固定方案与GnRH激动剂长方案在首次体外受精-胚胎移植周期中卵巢储备功能正常的不孕患者中的比较]
Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):245-9.
4
Gonadotrophin-releasing hormone antagonists for assisted conception.用于辅助生殖的促性腺激素释放激素拮抗剂
Cochrane Database Syst Rev. 2001(4):CD001750. doi: 10.1002/14651858.CD001750.
5
[Comparative Study of the Embryo Development and Clinical Outcomes of 3 Ovarian Stimulation Protocols in Different Age Groups].[不同年龄组3种卵巢刺激方案的胚胎发育及临床结局的比较研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):580-587. doi: 10.12182/20240560508.
6
GnRH antagonists in ovarian stimulation for IVF.用于体外受精卵巢刺激的促性腺激素释放激素拮抗剂
Hum Reprod Update. 2006 Jul-Aug;12(4):333-40. doi: 10.1093/humupd/dml001. Epub 2006 Mar 27.
7
[Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].促性腺激素释放激素拮抗剂在中国接受体外受精-胚胎移植控制性卵巢刺激的女性中的临床应用
Nan Fang Yi Ke Da Xue Xue Bao. 2007 May;27(5):588-90.
8
Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.35 岁及以上接受 IVF/ICSI 的女性中,重组 LH 补充到标准 GnRH 拮抗剂方案中:一项随机对照多中心研究。
Hum Reprod. 2013 Oct;28(10):2804-12. doi: 10.1093/humrep/det266. Epub 2013 Jul 9.
9
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.在接受体外受精的高危患者中,促性腺激素释放激素(GnRH)激动剂与GnRH拮抗剂联合治疗后用于诱导卵母细胞成熟可预防卵巢过度刺激综合征的风险:一项前瞻性随机对照研究。
Fertil Steril. 2008 Jan;89(1):84-91. doi: 10.1016/j.fertnstert.2007.02.002. Epub 2007 Apr 26.
10
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.两种卵巢刺激方案与促性腺激素释放激素(GnRH)拮抗剂联合治疗用于体外受精的随机比较,这两种方案分别是在周期第2天或第5天开始使用重组促卵泡激素并与标准长效GnRH激动剂方案进行对比。
J Clin Endocrinol Metab. 2003 Jan;88(1):166-73. doi: 10.1210/jc.2002-020788.

引用本文的文献

1
Buserelin shortens the estrus-to-ovulation interval and improves the pregnancy outcomes in gilts treated with a fixed-time artificial insemination.布舍瑞林可缩短后备母猪定时人工授精治疗后的发情至排卵间隔,并改善妊娠结局。
Front Vet Sci. 2025 Jun 18;12:1612713. doi: 10.3389/fvets.2025.1612713. eCollection 2025.
2
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.辅助生殖的控制性卵巢刺激方案:一项网状荟萃分析。
Cochrane Database Syst Rev. 2025 Jul 1;7(7):CD012586. doi: 10.1002/14651858.CD012586.pub2.
3
Effects of Different Gonadotropin-Releasing Hormone Agonists on IVF/ICSI-ET Outcomes in Long Protocol: A Retrospective Study.

本文引用的文献

1
An OHSS-Free Clinic by segmentation of IVF treatment.试管婴儿治疗分段,避免卵巢过度刺激综合征(OHSS)发生。
Hum Reprod. 2011 Oct;26(10):2593-7. doi: 10.1093/humrep/der251. Epub 2011 Aug 9.
2
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.用于辅助生殖技术的促性腺激素释放激素拮抗剂
Cochrane Database Syst Rev. 2011 May 11(5):CD001750. doi: 10.1002/14651858.CD001750.pub3.
3
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?促性腺激素释放激素激动剂触发卵母细胞最终成熟:是否需要改变实践?
长效方案中不同促性腺激素释放激素激动剂对体外受精/卵胞浆内单精子注射-胚胎移植结局的影响:一项回顾性研究
Int J Womens Health. 2025 May 8;17:1313-1320. doi: 10.2147/IJWH.S517738. eCollection 2025.
4
Progestin-primed ovarian stimulation for oocyte cryopreservation in patients with nonmedical indications: a case-control study.非医学指征患者孕激素预处理卵巢刺激用于卵母细胞冷冻保存的病例对照研究
Reprod Biol Endocrinol. 2025 May 9;23(1):64. doi: 10.1186/s12958-025-01402-2.
5
Clinical efficacy and pharmacological mechanism of Er Zhi Tian Gui formula in enhancing IVF-ET outcomes for diminished ovarian reserve.二至填归方提高卵巢储备功能低下患者体外受精-胚胎移植结局的临床疗效及药理机制
Front Pharmacol. 2025 Mar 21;16:1552581. doi: 10.3389/fphar.2025.1552581. eCollection 2025.
6
Smaller follicle diameter improves outcomes in natural LPOS: a retrospective cohort study.较小的卵泡直径可改善自然周期腹腔镜卵巢打孔术的结局:一项回顾性队列研究。
J Assist Reprod Genet. 2025 Apr;42(4):1287-1295. doi: 10.1007/s10815-025-03421-9. Epub 2025 Feb 11.
7
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.评估多发性硬化症女性体外受精后复发的风险。
Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200371. doi: 10.1212/NXI.0000000000200371. Epub 2025 Feb 11.
8
GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy.促性腺激素释放激素肽拮抗剂:化学与制剂的比较分析及其对临床安全性和有效性的影响
Pharmaceuticals (Basel). 2024 Dec 31;18(1):36. doi: 10.3390/ph18010036.
9
Ovarian sensitivity index affects clinical pregnancy and live birth rates in gonadotropin-releasing hormone agonist and antagonist fertilization cycles.卵巢敏感性指数影响促性腺激素释放激素激动剂和拮抗剂受精周期的临床妊娠率和活产率。
Front Endocrinol (Lausanne). 2024 Dec 13;15:1457435. doi: 10.3389/fendo.2024.1457435. eCollection 2024.
10
Effect of LH level on HCG trigger day on clinical outcomes in patients with diminished ovarian reserve undergoing GnRH-antagonist protocol.在接受 GnRH 拮抗剂方案治疗的卵巢储备功能减退患者中,LH 水平对 HCG 触发日的临床结局的影响。
Reprod Biol Endocrinol. 2024 Aug 22;22(1):107. doi: 10.1186/s12958-024-01280-0.
Hum Reprod Update. 2011 Jul-Aug;17(4):510-24. doi: 10.1093/humupd/dmr008. Epub 2011 Mar 30.
4
Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.《女性生育力保存——乳腺癌、霍奇金淋巴瘤和交界性卵巢肿瘤中生育力保存技术和治疗策略的实用指南》,由生育力保护网络 FertiPROTEKT 编写。
Arch Gynecol Obstet. 2011 Aug;284(2):427-35. doi: 10.1007/s00404-011-1874-1. Epub 2011 Mar 24.
5
Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols.预后良好患者首次体外受精周期刺激方案的选择:促性腺激素释放激素拮抗剂与激动剂方案对比
J Reprod Med. 2011 Jan-Feb;56(1-2):12-6.
6
Depot GnRH-agonist trigger for breast-cancer patient undergoing ovarian stimulation resulted in mature oocytes for cryopreservation: a case report.接受卵巢刺激的乳腺癌患者使用 GnRH 激动剂扳机导致成熟卵母细胞用于冷冻保存:病例报告。
Reprod Biomed Online. 2011 Mar;22(3):317-9. doi: 10.1016/j.rbmo.2010.11.015. Epub 2010 Nov 25.
7
Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis.促性腺激素释放激素激动剂与拮抗剂在卵母细胞捐赠者控制性卵巢超刺激中的应用:系统评价和荟萃分析。
Fertil Steril. 2011 Jan;95(1):164-9. doi: 10.1016/j.fertnstert.2010.06.068. Epub 2010 Aug 4.
8
Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis.促性腺激素释放激素拮抗剂周期中,口服避孕药预处理显著降低持续性妊娠的可能性:一项更新的荟萃分析。
Fertil Steril. 2010 Nov;94(6):2382-4. doi: 10.1016/j.fertnstert.2010.04.025. Epub 2010 May 26.
9
GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation.对于接受芳香化酶抑制剂/FSH 刺激进行生育保存的乳腺癌女性,使用 GnRH 激动剂触发。
Reprod Biomed Online. 2010 Jun;20(6):783-8. doi: 10.1016/j.rbmo.2010.03.004. Epub 2010 Mar 6.
10
Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis.低剂量 HCG 可能提高拮抗剂周期的妊娠率并降低 OHSS 风险:一项荟萃分析。
Reprod Biomed Online. 2009 Nov;19(5):619-30. doi: 10.1016/j.rbmo.2009.09.007.